Creative Planning’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Creative Planning's REGN Position: Q2 2026 in Review
Creative Planning reduced its Regeneron Pharmaceuticals (REGN) stake by 8% in Q2 2026, selling an estimated $2.18M and leaving 36,949 shares worth $23M. The position accounts for 0.01% of the portfolio, ranked #455.
Creative Planning first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $31M in Q1 2026. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Creative Planning held 36,949 shares of Regeneron Pharmaceuticals worth $23M as of Q2 2026.
- Creative Planning sold 3,203 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.18M.
- Regeneron Pharmaceuticals made up 0.01% of Creative Planning's portfolio in Q2 2026, its #455 holding.
- Creative Planning first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Creative Planning's Regeneron Pharmaceuticals position peaked at $31M in Q1 2026.
- 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.